Hematuria remains one of the most common urologic diagnoses, estimated to account for over 20% of urology evaluations. Women with hematuria have been especially prone to delays in evaluation, often due to practitioners ascribing hematuria to a urinary tract infection (UTI) or gynecologic source, resulting in inadequate evaluation and delay in cancer diagnosis. In this episode, we will review the recently released joint guidance form the AUA and SUFU regarding microhematuria. What defines this condition? If a UTI is also diagnosed, does that end the investigation? And what are the 3 risk profiles for microhematuria? Listen in for details!
Podden och tillhörande omslagsbild på den här sidan tillhör
Dr. Chapa’s Clinical Pearls. Innehållet i podden är skapat av Dr. Chapa’s Clinical Pearls och inte av,
eller tillsammans med, Poddtoppen.
